Status:
COMPLETED
Increasing Influenza and Tdap Vaccination of Pregnant Women
Lead Sponsor:
University of Rochester
Collaborating Sponsors:
Centers for Disease Control and Prevention
University of California, Los Angeles
Conditions:
Immunization; Infection
Pregnancy Related
Eligibility:
All Genders
Phase:
NA
Brief Summary
Pregnant women who get influenza are more likely than non-pregnant women to have serious complications, including hospitalizations, death, preterm labor and premature birth. Pertussis can cause hospit...
Detailed Description
Infants under 6 months of age at increased risk of both influenza (flu) and pertussis disease, and pregnant women risk serious illness and premature labor from flu. The Advisory Committee on Immunizat...
Eligibility Criteria
Inclusion
- Patients
- Sex is female
- Pregnant
- identified as being eligible for influenza or Tdap vaccine
- Providers
- any provider, nurse or staff associated with the participating sites
Exclusion
- Patients
- none
- Providers
- none
Key Trial Info
Start Date :
July 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
12760 Patients enrolled
Trial Details
Trial ID
NCT04444518
Start Date
July 1 2019
End Date
June 30 2022
Last Update
January 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Rochester Medical Center (URMC)
Rochester, New York, United States, 14642